Latest Breaking News On - ஹீனா கரணி - Page 1 : comparemela.com

-  Net assets per share 6.24 pence at 31 March 2021 (2020: 2.50 pence). -  Profit after tax of £3.09 million (2020: loss £0.30 million). -  Investments at 31 March 2021 valued at £5.11 million (2020: £1.18 million). -  Spend on new investments of £1.90 million (2020: £1.38 million).   -  Investment realisation proceeds of £1.21 million (2020: £2.03 million). -  Cash at 31 March 2021 of £0.05 million (2020: £0.90 million). -  Post year end raised gross cash proceeds of £4.11 million under a placing and open offer in April 2021. -  No part of the £3.00 million shareholder loan facility drawn down to date.     Whilst the arrival of a number of Covid-19 vaccines and the associated roll-out of the global vaccination programs should now provide a pathway for the gradual easing of th

United kingdomMichael brethertonJames caithieSandy jamiesonHeena karaniMental healthNomad cairn financial advisersCircassia pharmaceuticalsAfentra plcSource bioscience international plcInvestor relations company shareholder4d pharma plcAdams plcMotif bio plcOxehealth limitedCompany investing